The relationship between RSV (human respiratory syncytial virus) infections and invasive infections or pneumonia caused by Streptococcus pneumoniae has been observed epidemiologically for several years. Few fundamental data exist to support the epidemiological relationship. This study will investigate the proportion of pneumococcal carriage in RSV-infected infants and noninfected infants (proportion, serotype profile).
The relationship between RSV (human respiratory syncytial virus) infections and Streptococcus pneumoniae pneumonia has been suggested for many years based on a similar seasonal pattern and cohort studies, but it could not be confirmed due to the circulation of several viruses concurrently. The post-COVID-19 period was marked by a temporal association between RSV infections and invasive pneumococcal disease (and pneumonia) in children under five, highlighting the potential role of RSV in the dynamics of pneumococcal disease in infants. Furthermore, the carriage rate of S. pneumoniae in infants under 2 years of age in healthy populations is described as around 25%. In the case of RSV infection, this rate rises to 50%. Some data from animal models have shown that RSV infection increases S. pneumoniae transmission within a group of individuals, partly explaining this difference. However, data remain limited, particularly in human samples, and further research is needed to better understand the role of the RSV-pneumococcal relationship in the occurrence of severe RSV infections (pneumonia) and invasive pneumococcal infections. This study will examine pneumococcal carriage in bronchiolitis in infants aged 6-18 months, through nasopharyngeal swabs from infants with bronchiolitis and healthy infants. Pneumococcal carriage rates and serotype profiles will be investigated.
Study Type
OBSERVATIONAL
Enrollment
120
Nasopharyngeal swab
Hôpital Antoine Béclère
Clamart, France
nasopharyngeal carriage rate of Streptococcus pneumoniae (Sp)
Comparison of nasopharyngeal carriage rates of Streptococcus pneumoniae (Sp) in healthy infants and infants with RSV bronchiolitis.
Time frame: Inclusion
serotype profile
Comparison of the predominant serotype between the two groups.
Time frame: Inclusion
serotype profile
Comparison of the distribution of each serotype between the two groups.
Time frame: Inclusion
proportion of 13-valent and 23-valent vaccine serotypes
the proportion of 13-valent and 23-valent vaccine serotypes among pneumococcal strains between the two groups
Time frame: Inclusion
proportion of non-vaccine serotypes
proportion of non-vaccine serotypes among all pneumococcal strains between the two groups
Time frame: Inclusion
Serotype profile distribution
Serotypic Profile (Distribution of Serotypes) of S. pneumoniae in Nirsevimab-treated versus non-treated infants under 12 months of age, as assessed by nasopharyngeal swabs.
Time frame: Inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.